|
MAVS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.168700E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.970800E-04 |
| Normal-vs-Stage2 |
4.135400E-01 |
| Normal-vs-Stage3 |
8.20410000000882E-05 |
| Normal-vs-Stage4 |
3.417900E-04 |
| Stage1-vs-Stage2 |
3.232000E-02 |
| Stage1-vs-Stage3 |
2.210400E-01 |
| Stage1-vs-Stage4 |
3.061800E-01 |
| Stage2-vs-Stage3 |
4.383900E-03 |
| Stage2-vs-Stage4 |
8.558300E-03 |
| Stage3-vs-Stage4 |
9.284200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.185230E-04 |
| Normal-vs-AfricanAmerican |
4.983600E-02 |
| Normal-vs-Asian |
1.224430E-03 |
| Caucasian-vs-AfricanAmerican |
6.299400E-01 |
| Caucasian-vs-Asian |
8.809200E-01 |
| AfricanAmerican-vs-Asian |
5.728800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.181500E-03 |
| Normal-vs-Female |
2.408400E-04 |
| Male-vs-Female |
6.066000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.036000E-03 |
| Normal-vs-Age(41-60Yrs) |
3.960800E-04 |
| Normal-vs-Age(61-80Yrs) |
2.419000E-03 |
| Normal-vs-Age(81-100Yrs) |
7.677800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.028800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.134800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.802960E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.189400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.703200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.706640E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.941500E-03 |
| Classical-VS-Follicular |
2.286400E-01 |
| Classical-VS-Other |
2.433400E-01 |
| Classical-VS-Normal |
7.618800E-04 |
| Tall-VS-Follicular |
8.964100E-04 |
| Tall-VS-Other |
7.894600E-01 |
| Tall-VS-Normal |
1.52465999999629E-05 |
| Follicular-VS-Other |
1.783570E-01 |
| Follicular-VS-Normal |
8.390300E-02 |
| Other-VS-Normal |
1.905910E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.218100E-03 |
| Normal-vs-N1 |
1.56443999999034E-05 |
| N0-vs-N1 |
1.247870E-02 |
|
|
